Skip to main content
. Author manuscript; available in PMC: 2011 Sep 29.
Published in final edited form as: Transplantation. 2010 Aug 15;90(3):312–318. doi: 10.1097/TP.0b013e3181e49b9f

TABLE 1. UW-Madison renal transplants from deceased donors, 1993–2007.

Transplant type

Local >0MM Local 0MM Shipped >0MM Shipped 0MM P
n 1310 29 181 264
Recipient age (yr) 48.7±13.4 51.4±14.3 49.8±13.8 48.0±12.2 0.3
Donor age (yr) 42.5±17.5 36.5±16.9 38.75±18.7 34.7±14.9 <0.001
Tx No. 1.25±0.5 1.28±0.53 1.15±0.44 1.48±0.77 <0.001
Recipient BMI (kg/m2) 26.6±6.6 + 5.3 32.74±18.7 27.2±5.9 26.8±5.4 0.06
Donor BMI (kg/m2) 28.5±7.9 27.74±5.65 27.93±7.2 27.1±6.8 0.62
ESRD (mo) 14.8±11.6 19.5±12.3 13.4±10.8 17.3 ±11.9 <0.001
Peak PRA 12.75±23.3 17.6±29.6 7.6±17.4 25.4±34.0 <0.001
Cold storage time (hr) 2.98±6.4 5.6±9.1 14.4±8.4 12.2±7.4 <0.001
Total preservation time (hr) 22.5±6.9 21.4±5.9 25.1 ±5.9 23.2±5.9 <0.001
Race (% white)
 Recipients 79.8 93.1 77.3 94.3 <0.001
 Donors 94.7 96.6 80.4 94.7 <0.001
Gender (% male)
 Recipients 58.7 62.1 61.3 61.7 0.75
 Donors 60.3 72.4 54.7 59.5 0.27
High PRA (% ≥20) 17.6 27.6 8.8 35.2 <0.001
Diabetes (%) 24.7 44.8 24.9 32.6 0.006
Donor type (% SCD) 45.9 51.7 53.6 52.7 0.07
Induction immunosuppression
 Steroids (%) 99.9 100 100 99.6 0.46
 Calcineurin inhibitors (%) <0.001
   Cyclosporine 55.9 55.2 63.0 56.4
   Tacrolimus 25.0 31.0 21.0 36.0
   None 19.1 13.8 16.0 7.6
 Antiproliferatives (%) 0.6
   Azathioprine 14.7 6.9 17.7 11.7
   Mycophenolate 82.7 89.7 81.8 85.6

UW-Madison, University of Wisconsin, Madison; 0MM, 0-mismatch; Tx, transplant; BMI, body mass index; ESRD, end-stage renal disease; PRA, panel reactive antibodies.